Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Tijdschr Gerontol Geriatr ; 49(1): 1-11, 2018 Feb.
Artículo en Holandés | MEDLINE | ID: mdl-29181776

RESUMEN

In order to provide proactive care and support for older people attention is needed for the prevention of frailty among older adults. Subsequently, accurate case finding of those who are more at risk of becoming frail is crucial to undertake specific preventive actions. This study investigates frailty and risk profiles of frailty among older people in order to support proactive detection. Hereby, frailty is conceived not only as a physical problem, but also refers to emotional, social, and environmental hazards. Using data generated from the Belgian Ageing Studies (N = 21,664 home-dwelling older people), a multinomial logistic regression model was tested which included socio-demographic and socio-economic indicators as well as the four dimensions of frailty (physical, social, psychological and environmental). Findings indicate that for both men and women having moved in the previous 10 years and having a lower household income are risk factors of becoming multidimensional frail. However, studying the different frailty domains, several risk profiles arise (e. g. marital status is important for psychological frailty), and gender-specific risk groups are detected (e. g. non-married men). This paper elaborates on practical implications and formulates a number of future research recommendations to tackle frailty in an ageing society.


Asunto(s)
Envejecimiento/fisiología , Envejecimiento/psicología , Anciano Frágil , Medicina Preventiva/métodos , Anciano , Anciano de 80 o más Años , Ambiente , Femenino , Anciano Frágil/psicología , Fragilidad , Evaluación Geriátrica/métodos , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Clase Social
5.
Ned Tijdschr Geneeskd ; 145(8): 361-6, 2001 Feb 24.
Artículo en Holandés | MEDLINE | ID: mdl-11257816

RESUMEN

OBJECTIVE: To determine the differences in prescribing advice for statines in primary cardiovascular prevention, applying different protocols, in a first-line setting. METHOD: In February-March 2000, at the general practice 'Medicine for the People' in Deurne-Antwerp, Belgium, all contacts with patients known with at least one cardiovascular risk factor and no signs of cardiovascular disease were included in the study. The absolute risk of developing cardiovascular disease in the next 10 years was calculated per patient according to the protocols of the 'European Society of Cardiology' (ESC) and the Dutch College of General Practitioners (NHG) and it was determined whether these protocols advised prescription of statines. It was also determined if the Belgian criteria for repayment of statines, developed by the Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) were met. RESULTS: The study group comprised 143 patients with a mean age of 66 years, of which 51 (36%) were men. According to the RIZIV criteria 75 (52%) patients of these 143 were eligible for the repayment of statines. The NHG protocol advised to prescribe statines for 4 (3%) patients and the ESC protocol for 69 (48%) patients. Of the 75 patients who were considered for repayment, 34 (45%) according to the ESC protocol and 74 (99%) according to the NHG protocol did not need statines. Also, in the whole study population, 28 (20%) patients needed statines according to ESC and 3 (2%) patients according to NHG, but they could not get repayment for statines according to the RIZIV. The ESC protocol estimated the risk per patient on average 8.5% (95% confidence interval: 7.1-9.8; p < 0.0001) higher than the NHG protocol. CONCLUSION: The NHG protocol estimated the risk significantly and markedly lower than the European protocol, although they are both based on the same Framingham data. There also existed a weak concordance between both protocols. The RIZIV criteria were not 'evidence-based'. They incited to an irrational and wasting prescribing behaviour. There is a need for an integrated guideline for primary cardiovascular prevention and for the adjustment of the RIZIV criteria.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Medicina Familiar y Comunitaria/estadística & datos numéricos , Hiperlipidemias/tratamiento farmacológico , Hipolipemiantes/normas , Hipolipemiantes/uso terapéutico , Guías de Práctica Clínica como Asunto/normas , Anciano , Bélgica , Análisis Costo-Beneficio , Prescripciones de Medicamentos/normas , Prescripciones de Medicamentos/estadística & datos numéricos , Europa (Continente) , Femenino , Humanos , Hipolipemiantes/economía , Masculino , Persona de Mediana Edad , Países Bajos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA